Fore Capital LLC increased its position in Humana Inc. (NYSE:HUM – Free Report) by 119.0% in the 4th quarter, Holdings Channel reports. The firm owned 4,600 shares of the insurance provider’s stock after buying an additional 2,500 shares during the period. Humana makes up 0.4% of Fore Capital LLC’s holdings, making the stock its 19th biggest holding. Fore Capital LLC’s holdings in Humana were worth $1,178,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Illinois Municipal Retirement Fund raised its stake in Humana by 9.6% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock valued at $12,920,000 after acquiring an additional 4,351 shares during the last quarter. Long Focus Capital Management LLC purchased a new stake in Humana during the 3rd quarter valued at approximately $34,212,000. AMG National Trust Bank raised its stake in Humana by 106.5% during the 3rd quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock valued at $4,411,000 after acquiring an additional 8,744 shares during the last quarter. Aberdeen Group plc raised its stake in Humana by 18.1% during the 4th quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock valued at $72,684,000 after acquiring an additional 43,442 shares during the last quarter. Finally, Alberta Investment Management Corp purchased a new stake in Humana during the 3rd quarter valued at approximately $4,735,000. 92.38% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on HUM shares. Mizuho boosted their target price on Humana from $290.00 to $335.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 20th. Sanford C. Bernstein reiterated an “outperform” rating and set a $425.00 target price on shares of Humana in a research report on Wednesday. Needham & Company LLC started coverage on Humana in a research report on Wednesday, May 20th. They set a “buy” rating on the stock. UBS Group boosted their target price on Humana from $262.00 to $320.00 and gave the stock a “neutral” rating in a research report on Friday, May 22nd. Finally, Jefferies Financial Group upgraded Humana from a “buy” rating to a “buy” rating in a research report on Wednesday, May 20th. Nine equities research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $279.30.
Humana Stock Performance
HUM opened at $349.87 on Friday. The stock has a market cap of $42.01 billion, a P/E ratio of 37.42, a P/E/G ratio of 1.87 and a beta of 0.76. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The stock’s 50 day simple moving average is $244.92 and its 200 day simple moving average is $231.58. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $351.88.
Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company’s revenue was up 23.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, equities analysts anticipate that Humana Inc. will post 9 EPS for the current fiscal year.
Humana Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.0%. Humana’s dividend payout ratio is currently 37.86%.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Stories
- Five stocks we like better than Humana
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
